首页> 中文期刊> 《浙江临床医学》 >肺结核病蛋白质标志物筛选及临床价值研究

肺结核病蛋白质标志物筛选及临床价值研究

         

摘要

Objective To explore the scanning of tuberculosis biomarkers. Methods The enzyme-linked immunosorbent assays aimed on proteins related with the inflammatory state were performed. Result Alpha-1-antichymotrypsin(AACT),clusterin(CLU),and Ig alpha-1 chain C region(IGHA1) showed significantly reduced levels in cured pulmonary tuberculosis(TB) patients than untreated ones. Furthermore,the decision model established by these three proteins reached a sensitivity of 79.59%,and a specificity of 77.36%. Conclusion It is suggested that AACT,CLU, IGHA1 may be served as potential biomarkers for curing TB.%目的 探讨肺结核病蛋白质标志物的筛选方法.方法 利用酶联免疫吸附法筛选肺结核病的治愈标志物.结果 α-1抗胰糜蛋白酶(AACT)、丛生蛋白(CLU)、免疫球蛋白α-1链C区(IGHA1)3个蛋白质在治愈肺结核病患者中均较未用药组显著降低,并且由这3个蛋白质构建的判定模型的敏感度达79.59%,特异度达77.36%.结论 AACT、CLU、IGHA1有可能成为治愈肺结核病的血清标志物.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号